Related Experiment Videos
Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease
1Department of Pulmonology, University Hospital Maastricht, Maastricht, Netherlands. a.schols@pul.unimaas.nl
Clinics in Chest Medicine
|February 24, 2001
Summary
Patients with chronic obstructive pulmonary disease (COPD) often experience weight loss and muscle wasting due to decreased intake and increased energy needs. Nutritional support combined with exercise can improve outcomes for these depleted individuals.
Area of Science:
- Pulmonary Medicine
- Metabolic Disorders
- Nutritional Science
Background:
- Chronic obstructive pulmonary disease (COPD) is frequently associated with significant weight loss and muscle wasting.
- This wasting stems from reduced dietary intake and heightened energy expenditure in COPD patients.
- Altered metabolic pathways involving hormones, cytokines, and growth factors contribute to disproportionate muscle loss.
Purpose of the Study:
- To investigate the underlying causes of weight loss and muscle wasting in COPD.
- To evaluate the efficacy of nutritional interventions combined with anabolic stimuli.
- To explore future therapeutic strategies for managing catabolic responses in COPD.
Main Methods:
- Review of metabolic disturbances and mediator roles in COPD-related wasting.
- Analysis of studies combining nutritional supplementation with exercise interventions.
- Examination of potential nutritional and pharmacological approaches to modulate catabolism.
Main Results:
- Nutritional supplementation alongside exercise demonstrated improvements in functional capacity.
- Combined interventions positively impacted health status and reduced mortality in depleted COPD patients.
- Metabolic alterations play a crucial role in the pathophysiology of muscle wasting.
Conclusions:
- Nutritional support and exercise are effective strategies for managing weight loss and muscle wasting in COPD.
- Modulating the catabolic response holds promise for future therapeutic advancements.
- Addressing metabolic disturbances is key to improving patient outcomes in COPD.